Aurinia Pharmaceuticals (AUPH) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts AUPH Hot Sheet
Join SI Premium – FREE
Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
- Sunbelt Rentals Holdings, Inc. (SUNB) Reports Q2 EPS of $1.18
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
